Scholarlink

Background <p>Severe Covid-19 leads to higher neutralizing antibody levels, a key correlate of protection. However, the host proteins associated with this response have not been fully characterized. We asked which proteins in the blood plasma associate with neutralization, anti-spike antibody levels, and disease severity in a South African cohort upon first SARS-CoV-2 exposure.</p> Methods <p>We used a longitudinal observational cohort design to collect blood at 6 days (acute infection) and 32 days (convalescence) post-diagnosis. We performed SomaScan proteomics on acute blood plasma and measured SARS-CoV-2 plasma neutralization capacity and anti-spike antibody levels in convalescent plasma. Disease severity was scored based on requirement for supplemental oxygen and was mild to moderate (no critically ill participants).</p> Results <p>We find differentially expressed proteins associating with neutralization, anti-spike antibody levels, and disease severity, with strong overlap between proteins associated with&#xa0;neutralization and spike binding, and moderate overlap between neutralization and disease severity. High neutralizers, regardless of requirement for supplemental oxygen, are found to have risk factors and markers for being more ill compared to low neutralizers. We can reasonably predict who becomes a high neutralizer based on individual proteins. The best predictor for neutralization is HSPA8, known to bind viral proteins and cross-present extracellular antigens. The strongest associated pathway is fatty acid metabolism, whose inhibition results in suppression of viral replication.</p> Conclusions <p>These results show that host proteins and pathways involved early in SARS-CoV-2 infection associate with neutralizing antibody levels elicited by the infection at convalescence.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Host proteins associated with strong neutralizing SARS-CoV-2 antibody responses in a South African cohort

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月13日

查看全文
  • Afrah Khairallah,
  • Zesuliwe Jule,
  • Alice Piller,
  • Mallory Bernstein,
  • Kajal Reedoy,
  • Yashica Ganga,
  • Sashkia R. Balla,
  • Prudence Kgagudi,
  • Bernadett I. Gosnell,
  • Farina Karim,
  • Mahomed-Yunus S. Moosa,
  • Thumbi Ndung’u,
  • Thandeka Moyo-Gwete,
  • Penny L. Moore,
  • Khadija Khan,
  • Alex Sigal

摘要

Background

Severe Covid-19 leads to higher neutralizing antibody levels, a key correlate of protection. However, the host proteins associated with this response have not been fully characterized. We asked which proteins in the blood plasma associate with neutralization, anti-spike antibody levels, and disease severity in a South African cohort upon first SARS-CoV-2 exposure.

Methods

We used a longitudinal observational cohort design to collect blood at 6 days (acute infection) and 32 days (convalescence) post-diagnosis. We performed SomaScan proteomics on acute blood plasma and measured SARS-CoV-2 plasma neutralization capacity and anti-spike antibody levels in convalescent plasma. Disease severity was scored based on requirement for supplemental oxygen and was mild to moderate (no critically ill participants).

Results

We find differentially expressed proteins associating with neutralization, anti-spike antibody levels, and disease severity, with strong overlap between proteins associated with neutralization and spike binding, and moderate overlap between neutralization and disease severity. High neutralizers, regardless of requirement for supplemental oxygen, are found to have risk factors and markers for being more ill compared to low neutralizers. We can reasonably predict who becomes a high neutralizer based on individual proteins. The best predictor for neutralization is HSPA8, known to bind viral proteins and cross-present extracellular antigens. The strongest associated pathway is fatty acid metabolism, whose inhibition results in suppression of viral replication.

Conclusions

These results show that host proteins and pathways involved early in SARS-CoV-2 infection associate with neutralizing antibody levels elicited by the infection at convalescence.